Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I multiple-ascending dose clinical trial of APD371

Trial Profile

A phase I multiple-ascending dose clinical trial of APD371

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 20 Oct 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Olorinab (Primary)
  • Indications Abdominal pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 23 Sep 2020 Results assessing safety and PK of single and multiple doses of olorinab in healthy adults from SAD and MAD studies presented at the 2020 American College of Clinical Pharmacology Annual Meeting
    • 21 Mar 2020 Results assessing single and multiple dose PK and safety of olorinab in healthy adult subjects, presented at the 121st Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 07 Feb 2019 According to an Arena Pharmaceuticals media release, data from the study will be presented at Crohn's & Colitis Congress 2019.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top